Works matching IS 13524585 AND DT 2018 AND VI 24 AND IP 8
Results: 19
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1014, doi. 10.1177/1352458518775550
- By:
- Publication type:
- Article
Rebound disease in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1137, doi. 10.1177/1352458518772913
- By:
- Publication type:
- Article
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Studying the blood–brain barrier will provide new insights into neurodegeneration – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1026, doi. 10.1177/1352458518759430
- By:
- Publication type:
- Article
Studying the blood–brain barrier will provide new insights into neurodegeneration – No.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1025, doi. 10.1177/1352458518755564
- By:
- Publication type:
- Article
Studying the blood–brain barrier will provide new insights into neurodegeneration – Yes.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1023, doi. 10.1177/1352458518754367
- By:
- Publication type:
- Article
Fulminant rebound of relapsing–remitting multiple sclerosis after discontinuation of dimethyl fumarate: A case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
How to pursue EPO in MS.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1055, doi. 10.1177/1352458517715811
- By:
- Publication type:
- Article
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1046, doi. 10.1177/1352458517715132
- By:
- Publication type:
- Article
In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1029, doi. 10.1177/1352458517711568
- By:
- Publication type:
- Article
Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977–2015: A nationwide population-based incidence study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1077, doi. 10.1177/1352458517713669
- By:
- Publication type:
- Article
Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1126, doi. 10.1177/1352458517713667
- By:
- Publication type:
- Article
Dietary factors and pediatric multiple sclerosis: A case-control study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1067, doi. 10.1177/1352458517713343
- By:
- Publication type:
- Article
Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1115, doi. 10.1177/1352458517712078
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1039, doi. 10.1177/1352458517711774
- By:
- Publication type:
- Article
Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registry.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1087, doi. 10.1177/1352458517713668
- By:
- Publication type:
- Article
Changes to the septo-fornical area might play a role in the pathogenesis of anxiety in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1105, doi. 10.1177/1352458517711273
- By:
- Publication type:
- Article
A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 8, p. 1096, doi. 10.1177/1352458517709955
- By:
- Publication type:
- Article